MGC Pharmaceuticals Is Applying for a License to Grow Cannabis in Australia
MGC Pharmaceuticals will grow cannabis in Australia as part of its plan for the medicinal cannabis market.
Releasing a five-point plan for the local market, the company says it is working on applying for a growing license from relevant state departments
A short time ago, its shares were up more than 10% to $0.031.
Co-founder Nativ Segev says the medicinal cannabis market in Australia is an emerging opportunity for Australian patients, growers and the pharmaceutical industry.
“As Australia places itself on the global medicinal cannabis map, MGC Pharmaceuticals plans to play a crucial leadership role in the development of the domestic industry,” he says.
The five point strategy:
- An Australian medicinal cannabis growing license. MGC Pharmaceuticals is applying for a medicinal cannabis growing license from the states. It will focus on creating a pipeline for Australian grown cannabis to be provided to Australian patients, with the potential for growing additional ...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin